Areti Health, a clinical trial recruitment innovator, has secured Preface Ventures and Almaz Capital funding. This investment will support their mission to utilize generative AI to transform the industry.
Areti Health’s technology streamlines recruitment by engaging patients, automating scheduling, and analyzing patient data. Its AI-powered coordinator communicates in multiple languages, expanding access for diverse populations.
The end-to-end solution encompasses lead-sourcing campaigns, EMR integration, and real-time scheduling. Integrating CTMS systems and partnering with CRIO, Areti Health ensures seamless data flow and patient record management.
Clinical research teams using Areti Health’s AI Coordinator have experienced up to 10 times faster recruitment, improved efficiency, reduced advertising costs, and increased patient satisfaction. The technology eliminates routine tasks, freeing staff time for more complex tasks.
Areti Health is committed to revolutionizing clinical trial recruitment through customizable, end-to-end solutions. The company aims to establish itself as a market leader in recruitment, providing value to clients and advancing the industry.
Source link: https://www.aretihealth.com/areti-health-announces-seed-round/
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Ferry, a computer data scientist, focuses on the latest clinical trial industry news and trends.
